Boston Scientific seeks permission to add a $41 million manufacturing facility to its Irish campus to house the neurovascular unit that Stryker purchased earlier this year.

MASSDEVICE ON CALL —Boston Scientific Corp. (NYSE:BSX) began seeking approval for a $41 building project in Ireland to house the neurovascular unit it sold to Stryker Corp. (NYSE:SYK) earlier this year.
The 100,000 square foot facility will live on Boston Scientific's Cork, Ireland, campus but will be operated by Stryker, and some 600 local BSX employees will transfer to the new facility when it's ready.
Covidien champions positive results for the Barrett's esophagus ablation device it acquired along...
Illinois healthcare giant Abbott lands European regulatory approval for the Xience Xpedition 48,...
ALung Technologies says it's going for a Chinese regulatory nod for its Hemolung respiratory assist...
An attorney for a plaintiff suing robot-assisted surgical systems maker Intuitive Surgical says the...
The American Stroke Assn. and partners release the Spot a Stroke F.A.S.T. smartphone app to help...